Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report
Summary
Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Hikma Pharmaceuticals PLC (Hikma or 'the company') is a developer, manufacturer and marketer of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including: anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various forms such as injectable, oral and other non-injectable generic products. The company markets its products through sales and marketing teams. Its major customers in the US and Europe include pharmacy chains, wholesalers, governments and hospital purchasing organizations. Hikma markets products to doctors and pharmacists in Middle East and North Africa region through its representatives. The company primarily operates in the Middle East and North Africa, the US, and Europe. The company is headquartered in London, Greater London, the UK
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook